Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct 22;3(4):260-281.
doi: 10.3390/diseases3040260.

Synergistic Anticancer Activities of Natural Substances in Human Hepatocellular Carcinoma

Affiliations
Review

Synergistic Anticancer Activities of Natural Substances in Human Hepatocellular Carcinoma

Akiko Kojima-Yuasa et al. Diseases. .

Abstract

Hepatocellular carcinoma (HCC) is highly resistant to currently available chemotherapeutic agents. The clinical outcome of HCC treatment remains unsatisfactory. Therefore, new effective and well-tolerated therapy strategies are needed. Natural products are excellent sources for the development of new medications for disease treatment. Recently, we and other researchers have suggested that the combined effect of natural products may improve the effect of chemotherapy treatments against the proliferation of cancer cells. In addition, many combination treatments with natural products augmented intracellular reactive oxygen species (ROS). In this review we will demonstrate the synergistic anticancer effects of a combination of natural products with chemotherapeutic agents or natural products against human HCC and provide new insight into the development of novel combination therapies against HCC.

Keywords: chemotherapeutic agents; combination treatment; hepatocellular carcinoma (HCC); natural products; reactive oxygen species (ROS); synergistic anticancer effect.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

Cited by

References

    1. Jemal A., Bray F., Center M.M., Ferlay J., Forman D. Grobal cancer statistics. CA Cancer J. Clin. 2001;61:69–90. doi: 10.3322/caac.20107. - DOI - PubMed
    1. Polakis P. Wnt signaling in cancer. Cold Spring Harb. Perspect. Biol. 2012;4 doi: 10.1101/cshperspect.a008052. - DOI - PMC - PubMed
    1. Aravalli R.N., Steer C.J., Cressman E.N. Molecular mechanisms of hepatocellular carcinoma. Hepatology. 2008;48:1049–1053. doi: 10.1002/hep.22580. - DOI - PubMed
    1. Delire B., Stärkel P. The Ras/MAPK pathway and hepatocarcinoma: Pathogenesis and therapeutic implications. Eur. J. Clin. Investig. 2015;45:609–623. doi: 10.1111/eci.12441. - DOI - PubMed
    1. Goodrich D.W. The retinoblastoma tumor-suppressor gene, the exception that proves the rule. Oncogene. 2006;25:5233–5243. doi: 10.1038/sj.onc.1209616. - DOI - PMC - PubMed

LinkOut - more resources